Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.84	46.31	57.06
Graham Fair Price	-5.28	14.37	15.17
PEG	218.63	-7.77	2.44
Price/Book	-5.90	-13.77	-13.01
Price/Cash Flow	1552.81	-806.85	48.82
Prices/Earnings	-0.57	16.53	16.62
Price/Sales	0.40	16.20	16.14
Price/FCF	1552.81	-806.85	48.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.01	0.62	0.62
Operating Margin	32.17	0.42	0.32
ROA	-2.20	0.03	0.03
ROE	-0.20	-0.21	-6.51
ROIC	0.07	0.07	0.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	< 0.005	1172.15
Dividends QOQ	0.02	< 0.005	-73.04
EBIT QOQ	-0.14	0.28	96.44
EPS QOQ	0.07	-0.02	-68.79
FCF QOQ	-0.02	-1.06	-5981.36
Revenue QOQ	-0.01	-0.03	-204.19
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	280.09	271.99	-2.89
Days Sales Outstanding (DSO)	43.68	51.88	18.77
Inventory Turnover	0.32	0.33	2.98
Debt/Capitalization	1.31	1.26	-3.73
Quick Ratio	0.28	0.41	46.15
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-7.23	-6.64	8.22
Cash	1.97	2.64	33.82
Capex	-0.20	-0.27	-34.00
Free Cash Flow	1.93	-0.11	-94.12
Revenue	5.83	5.64	-3.19
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.75	0.94	25.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.41	11.38	-15.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating